Explore our comprehensive range of genetic tests for hereditary cancers, precision oncology, carrier screening, rare diseases, pharmacogenomics and preventive healthcare.
Detect hereditary breast and ovarian cancer-associated mutations with high analytical accuracy using Next Generation Sequencing technology.
Choose from our advanced range of cancer screening, hereditary disease and precision medicine tests.
Comprehensive analysis of 7000 genes, including targeted atypical Hemolytic Uremic Syndrome (aHUS) genes for accurate diagnosis of rare inherited disorders.
Liquid biopsy for comprehensive genomic profiling of solid tumors.
AI-powered prognostic test for early-stage breast cancer.
Comprehensive analysis of approximately 20,000 protein-coding genes to identify genetic variants associated with inherited and rare disorders.
Analyze 46 clinically relevant genes associated with aplastic anaemia using advanced Next-Generation Sequencing to support accurate diagnosis and personalized patient care.
Advanced genomic testing combining Whole Exome Sequencing and complete Mitochondrial Genome Sequencing to support the diagnosis of rare and inherited genetic disorders.
Advanced genetic wellness screening that analyzes your DNA to deliver personalized recommendations for nutrition, fitness, medication response and long-term health through the Genieee App.
Comprehensive genetic testing of 14 HLH-associated genes, including key disease drivers, to support the diagnosis of Hemophagocytic Lymphohistiocytosis (HLH).
Advanced NGS panel that analyzes clinically relevant DNA mutations, copy number variations, indels and gene fusions to support the diagnosis, prognosis and treatment selection for thyroid cancers.
Our specialists can help you choose the most appropriate genetic test based on your personal health history, family history and clinical requirements.